Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Home
Alembic Pharmaceuticals Limited
Press Release Jan 06 2023
Business
Jan 6 2023
4 min read

Press Release Jan 06 2023

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 06, 2023, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Fesoterodine Fumarate Extended-Release Tablets, 4 mg and 8 mg".

View Attachment